BACKGROUND: Some patients with heart failure (HF) may have a marked improvement in left ventricular ejection fraction (LVEF) after long-term beta-blockade. We compared the clinical characteristics and the prognosis of these patients with those of other patients. METHODS: One hundred seventy-one patients with chronic HF were assessed before and after 9 to 12 months of maintenance therapy with metoprolol or carvedilol. RESULTS: Thirty-eight patients (22%) showed an increase in their LVEF >or=15 units (from 20% +/- 8% to 43% +/- 10%). Compared with the other patients (LVEF change from 21% +/- 7% to 26% +/- 9%, P <.0001 for differences between groups), these patients also had a greater decline in the left ventricular end-diastolic volume (from 175 +/- 74 mL/m(2) to 113 +/- 36 mL/m(2)) and in the right atrial, mean pulmonary artery, and pulmonary wedge pressures, with a greater increase in the cardiac index, stroke volume index, stroke work index, and maximal functional capacity. Their long-term prognosis was excellent, with a 2-year cumulative survival rate of 95%, versus 81% for the other patients, and a hospitalization-free survival rate of 73%, versus 50% for the other patients (all P <.05). By means of multivariate analysis, only the nonischemic cause of HF and the mean arterial pressure at baseline were independently associated with an increase of >or=0.15 in LVEF. CONCLUSIONS: Patients who show a marked improvement in their LVEF after long-term beta-blockade have an excellent prognosis and have a high prevalence of nonischemic HF and a higher blood pressure at baseline.
BACKGROUND: Some patients with heart failure (HF) may have a marked improvement in left ventricular ejection fraction (LVEF) after long-term beta-blockade. We compared the clinical characteristics and the prognosis of these patients with those of other patients. METHODS: One hundred seventy-one patients with chronic HF were assessed before and after 9 to 12 months of maintenance therapy with metoprolol or carvedilol. RESULTS: Thirty-eight patients (22%) showed an increase in their LVEF >or=15 units (from 20% +/- 8% to 43% +/- 10%). Compared with the other patients (LVEF change from 21% +/- 7% to 26% +/- 9%, P <.0001 for differences between groups), these patients also had a greater decline in the left ventricular end-diastolic volume (from 175 +/- 74 mL/m(2) to 113 +/- 36 mL/m(2)) and in the right atrial, mean pulmonary artery, and pulmonary wedge pressures, with a greater increase in the cardiac index, stroke volume index, stroke work index, and maximal functional capacity. Their long-term prognosis was excellent, with a 2-year cumulative survival rate of 95%, versus 81% for the other patients, and a hospitalization-free survival rate of 73%, versus 50% for the other patients (all P <.05). By means of multivariate analysis, only the nonischemic cause of HF and the mean arterial pressure at baseline were independently associated with an increase of >or=0.15 in LVEF. CONCLUSIONS:Patients who show a marked improvement in their LVEF after long-term beta-blockade have an excellent prognosis and have a high prevalence of nonischemic HF and a higher blood pressure at baseline.
Authors: Shannon M Dunlay; Véronique L Roger; Susan A Weston; Ruoxiang Jiang; Margaret M Redfield Journal: Circ Heart Fail Date: 2012-08-30 Impact factor: 8.790
Authors: Mohsin Khan; Sadia Mohsin; Daniele Avitabile; Sailay Siddiqi; Jonathan Nguyen; Kathleen Wallach; Pearl Quijada; Michael McGregor; Natalie Gude; Roberto Alvarez; Douglas G Tilley; Walter J Koch; Mark A Sussman Journal: Circ Res Date: 2012-12-14 Impact factor: 17.367